In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The FTC Takes a Closer Look at Consolidation

Executive Summary

The Federal Trade Commission's objections to the Abbott/Alza merger sank the deal--despite the companies' attempt to satisfy the FTC with a divestiture of the product at issue, Viadur. The implications: an increasingly aggressive FTC, with a much stricter sense of what constitutes anti-competitiveness, may require much different remedies from merging companies. But they're not saying what.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

IV001112

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel